According to a new report, published by KBV research, The Global Rat Model Market size is expected to reach $1.7 billion by 2028, rising at a market growth of 7.4% CAGR during the forecast period.
The Embryonic Stem Cell & Microinjection market is exhibiting a CAGR of 7.8% during (2022 - 2028). The expansion of the recognition of CRISPR-Cas9 for the Nobel Prize in Chemistry in 2020 has changed biological research. This technology has been used to create several rat models for use in drug-related research. A number of knockout rat models have been produced utilizing this technology.
The Outbred market is leading the segment in the Global Rat Model Market by Type in 2021; thereby, achieving a market value of $444.4 million by 2028. The outbred rats more accurately resemble the genetic variability of humans, resulting in their extensive usage in preclinical research. This adds to the increased proportion of crossbred models. These outbred rats are morphologically stable to a certain extent and far less vulnerable to environmental fluctuations, making them ideal for simulating the genetic abnormalities that lead to illnesses.
The Cryopreservation market is showcasing a CAGR of 7.8% during (2022 - 2028). This service comprises the ultra-freezing of embryos, sperm, and even study strains of the rat, as well as the creation of a cost-effective plan for storing and backing up the necessary models for future use. These cryoservices also preserve the intended model from contamination, natural disasters, unintended accidents, and gene modification or drift in future generations.
The Toxicology market is generating high revenue in the Global Rat Model Market by Application in 2021; thereby, achieving a market value of $660.8 million by 2028. Continuous demand for medications and therapies prompted the government and major healthcare providers to increase their investments. This insatiable desire for novel pharmaceuticals and therapies pushes research initiatives to improve the health infrastructure.
The Pharmaceutical & Biotechnology Companies market is registering a CAGR of 7.6% during (2022 - 2028). The expanded use of the rat model in the research and development pipeline and the manufacturing of medications and vaccines for autoimmune illnesses and infectious diseases have increased income generation. In addition, prominent actors are entering into exclusive agreements and collaborations to promote the commercialization of breakthrough research methods.
The North America market dominated the Global Rat Model Market by Region in 2021; thereby, achieving a market value of $648.3 million by 2028. The Europe market is anticipated to grow at a CAGR of 6.7% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 8.5% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/rat-model-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Inotiv, Inc., genOway, Janvier Labs, Taconic Biosciences, Inc. (H.I.G. Capital), TransViragen, Inc., Biomedical Research Models, Inc. (Biomere) and Cyagen Biosciences.
By Technology
By Type
By Service
By Application
By End-use
By Geography
Companies Profiled
Unique Offerings 
